Synairgen PLC's (LON:SNG) Richard Marsden says a trial of its treatment for people with coronavirus (COVID-19) is being expanded nationally with participants receiving the inhaled drug in their homes.
He says results from the study of 100 patients successfully treated with the SNG001 treatment in hospital are set to be released next month.
Details for those interested in taking part in the home trial can be found at www.covidtrialathome.com
